Review



rat ctx-ii (type ii collagen c-terminal cross-linked peptide) elisa kit e-elr2554  (Elabscience Biotechnology)


Bioz Verified Symbol Elabscience Biotechnology is a verified supplier
Bioz Manufacturer Symbol Elabscience Biotechnology manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 90

    Structured Review

    Elabscience Biotechnology rat ctx-ii (type ii collagen c-terminal cross-linked peptide) elisa kit e-elr2554
    Rat Ctx Ii (Type Ii Collagen C Terminal Cross Linked Peptide) Elisa Kit E Elr2554, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat ctx-ii (type ii collagen c-terminal cross-linked peptide) elisa kit e-elr2554/product/Elabscience Biotechnology
    Average 90 stars, based on 1 article reviews
    rat ctx-ii (type ii collagen c-terminal cross-linked peptide) elisa kit e-elr2554 - by Bioz Stars, 2026-04
    90/100 stars

    Images



    Similar Products

    96
    ATCC tularensis a ii wyoming human 2006 ut udhl 70102163 f
    Tularensis A Ii Wyoming Human 2006 Ut Udhl 70102163 F, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/tularensis a ii wyoming human 2006 ut udhl 70102163 f/product/ATCC
    Average 96 stars, based on 1 article reviews
    tularensis a ii wyoming human 2006 ut udhl 70102163 f - by Bioz Stars, 2026-04
    96/100 stars
      Buy from Supplier

    90
    Elabscience Biotechnology rat ctx-ii (type ii collagen c-terminal cross-linked peptide) elisa kit e-elr2554
    Rat Ctx Ii (Type Ii Collagen C Terminal Cross Linked Peptide) Elisa Kit E Elr2554, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat ctx-ii (type ii collagen c-terminal cross-linked peptide) elisa kit e-elr2554/product/Elabscience Biotechnology
    Average 90 stars, based on 1 article reviews
    rat ctx-ii (type ii collagen c-terminal cross-linked peptide) elisa kit e-elr2554 - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    94
    BioVendor Instruments human ctx ii
    Human Ctx Ii, supplied by BioVendor Instruments, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/human ctx ii/product/BioVendor Instruments
    Average 94 stars, based on 1 article reviews
    human ctx ii - by Bioz Stars, 2026-04
    94/100 stars
      Buy from Supplier

    90
    Novus Biologicals ctx ii
    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, <t>CTX-II</t> and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence <t>markers</t> <t>(p16</t> INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.
    Ctx Ii, supplied by Novus Biologicals, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctx ii/product/Novus Biologicals
    Average 90 stars, based on 1 article reviews
    ctx ii - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Absolute Biotech Inc ctx-ii
    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, <t>CTX-II</t> and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence <t>markers</t> <t>(p16</t> INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.
    Ctx Ii, supplied by Absolute Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/ctx-ii/product/Absolute Biotech Inc
    Average 90 stars, based on 1 article reviews
    ctx-ii - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    FineTest Biotech Inc rat ctx-ii elisa kit
    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, <t>CTX-II</t> and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence <t>markers</t> <t>(p16</t> INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.
    Rat Ctx Ii Elisa Kit, supplied by FineTest Biotech Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/rat ctx-ii elisa kit/product/FineTest Biotech Inc
    Average 90 stars, based on 1 article reviews
    rat ctx-ii elisa kit - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Elabscience Biotechnology cross-linked c-terminal telopeptide of type ii collagen (ctx-ii)
    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, <t>CTX-II</t> and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence <t>markers</t> <t>(p16</t> INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.
    Cross Linked C Terminal Telopeptide Of Type Ii Collagen (Ctx Ii), supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/cross-linked c-terminal telopeptide of type ii collagen (ctx-ii)/product/Elabscience Biotechnology
    Average 90 stars, based on 1 article reviews
    cross-linked c-terminal telopeptide of type ii collagen (ctx-ii) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Elabscience Biotechnology elisa kit rat cross-linked c-telopeptide of type 2 collagen (ctx-ii; cat no. e-elr2554)
    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, <t>CTX-II</t> and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence <t>markers</t> <t>(p16</t> INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.
    Elisa Kit Rat Cross Linked C Telopeptide Of Type 2 Collagen (Ctx Ii; Cat No. E Elr2554), supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/elisa kit rat cross-linked c-telopeptide of type 2 collagen (ctx-ii; cat no. e-elr2554)/product/Elabscience Biotechnology
    Average 90 stars, based on 1 article reviews
    elisa kit rat cross-linked c-telopeptide of type 2 collagen (ctx-ii; cat no. e-elr2554) - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    Cloud-Clone corp urinary ctx-ii
    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, <t>CTX-II</t> and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence <t>markers</t> <t>(p16</t> INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.
    Urinary Ctx Ii, supplied by Cloud-Clone corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/urinary ctx-ii/product/Cloud-Clone corp
    Average 90 stars, based on 1 article reviews
    urinary ctx-ii - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    90
    MyBiosource Biotechnology c-terminal cross-linked telopeptides of type ii collagen (ctx ii) elisa kit
    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, <t>CTX-II</t> and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence <t>markers</t> <t>(p16</t> INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.
    C Terminal Cross Linked Telopeptides Of Type Ii Collagen (Ctx Ii) Elisa Kit, supplied by MyBiosource Biotechnology, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/result/c-terminal cross-linked telopeptides of type ii collagen (ctx ii) elisa kit/product/MyBiosource Biotechnology
    Average 90 stars, based on 1 article reviews
    c-terminal cross-linked telopeptides of type ii collagen (ctx ii) elisa kit - by Bioz Stars, 2026-04
    90/100 stars
      Buy from Supplier

    Image Search Results


    a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, CTX-II and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence markers (p16 INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.

    Journal: Nature Communications

    Article Title: Regulation of senescence-associated secretory phenotypes in osteoarthritis by cytosolic UDP-GlcNAc retention and O-GlcNAcylation

    doi: 10.1038/s41467-024-55085-1

    Figure Lengend Snippet: a Twelve-week-old WT C57BL/6 J mice underwent DMM surgery followed by weekly IA injection of vehicle or thiamet-G. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified below and on the right. b Cartilage destruction and synovial inflammation were scored ( n = 8, 9 respectively). c The percentage of weight placed on the DMM-operated limb versus the contralateral limb of the WT mice injected with vehicle or thiamet-G, determined using a static weight bearing test ( n = 8, 9 respectively). d GSEA of the “Upregulated genes in OA” gene set in chondrocytes treated with bleomycin for 24 h followed by vehicle or ST045849 treatment for five days. e Twelve-week-old WT C57BL/6 J mice received DMM surgery followed by weekly IA injection of vehicle or ST045849 using a hydrogel-based drug delivery system. Joint sections were stained with safranin O, fast green, and hematoxylin, with insets magnified on the right. f – h Immunohistochemistry of ( f ) GATA4 and cartilage matrix neoepitopes (C-telopeptide of type II collagen, CTX-II and aggrecan neoepitope, NITEGE), ( g ) MMP3, MMP13, IL-6, ( h ) senescence markers (p16 INK4a and HMGB1), and HGF in cartilage sections from DMM-operated WT mice followed by IA injection with vehicle or ST045849 ( n = 3). i Cartilage destruction, subchondral bone sclerosis, osteophyte formation, and synovial inflammation were scored ( n = 10). j Percentage of weight placed on the DMM-operated limb versus the contralateral limb of WT mice injected with vehicle or ST045849, determined using a static weight bearing test ( n = 10). k Electronic Von Frey test in ipsilateral hindpaw of sham- or DMM-operated WT mice IA-injected with vehicle or ST045849 using a hydrogel-based drug delivery system ( n = 10). Scale bars: a, e , 200 μm, f – h , 25 μm. b, c, i – k Data represent means ± s.e.m. P values are from two-tailed Mann–Whitney U test ( b, i ), two-tailed t test ( c, j, k ), or one-tailed permutation test corrected for multiple comparisons with FWER ( d ). Source data are provided as a Source Data file.

    Article Snippet: Primary antibodies used for immunohistochemical staining were as follows: O-GlcNAc (clone RL2, Abcam, ab2739, 1:50–100), p16 INK4a (Proteintech, 10883-1-AP, 1:100; against human p16 INK4a ), GATA4 (clone G-4, Santa Cruz, sc-25310, 1:50–100), IL-6 (clone 1, Santa Cruz, sc-130326, 1:50–100), MMP3 (clone EP1186Y, Abcam, ab52915, 1:50–100), MMP13 (EP1263Y, Abcam, ab51072, 1:50–100), p16 INK4a (clone EPR20418, Abcam, ab211542, 1:50–100; against mouse p16 INK4a ), HMGB1 (Abcam, ab18256, 1:100), HGF (Novus, AF2207, 1:50), CTX-II (Novus, NBP2-59386, 1:100), NITEGE (clone BC-13, MD Bioproducts, 1042003, 1:100), and ADAMTS5 (Abcam, ab41037, 1:100).

    Techniques: Injection, Staining, Immunohistochemistry, Two Tailed Test, MANN-WHITNEY, One-tailed Test